Treatment of alzheimer's disease with 5-(tetradecyloxy)-2-furan carboxylic acid
US5607967A · kind A · utility
15Cited by
1References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 27, 1994 |
| Grant date | Mar 4, 1997 |
| Priority date | — |
| Expiry date | Oct 27, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Use of the novel receptor NER TOFA (5-(tetradecyloxy)-2-furan-carboxylic acid) to treat Alzheimer's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.